Apotex Defeats Allergan's New Suit Over Pinkeye Patent
By Django Gold ( September 18, 2012, 1:32 PM EDT) -- Allergan Inc. and two Japanese pharmaceutical companies on Monday failed in their renewed efforts to target Apotex Inc. for infringement of a patent used in Allergan's pinkeye treatment Zymar after a Delaware federal judge said a re-examination of the patent couldn't breathe life into the previously resolved dispute....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.